Cambridge, Massachusetts, United States
Jaclyn L. F. Bosco, PhD, MPH, FISPE is the Global Head of Epidemiology and Outcomes Research in Real World Solutions at IQVIA. Dr. Bosco is thought leader in the biologics and biosimilars area and has been invited to present at international congresses and conferences to speak on the topic of generating real-world evidence for biosimilars with regulators (e.g., FDA, EMA Biosimilars Working Party) and policy makers. She is invited to speak at international congresses on the topic of regulatory use of real world evidence, serves as a member of the Science Committee and Methods groups of the U.S. Biologics and Biosimilars Collective Intelligence Consortium (BBCIC), and publishes on the design and considerations of real world studies of biologics and biosimilars. Dr. Bosco is the immediate past-chair of the ISPE Education Committee, the course coordinator and faculty member for the ISPE pre-conference pharmacoepidemiology course on biologics including biosimilars, a member of the Biologics/Biosimilars SIG, and was inducted as an ISPE Fellow (FISPE) in 2019. She is an Adjunct Assistant Professor at Boston University School of Public Health, where she received her PhD in Epidemiology and MPH in Epidemiology and Biostatistics. She also completed her research fellowship with Dana Farber Cancer Institute/Harvard Medical School.